Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond

The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with major depressive disorder offer the hope of a new era in treating mood and anxiety...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neurobiol Stress
Hoofdauteurs: Zorumski, Charles F., Paul, Steven M., Covey, Douglas F., Mennerick, Steven
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2019
Onderwerpen:
Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804800/
https://ncbi.nlm.nih.gov/pubmed/31649968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ynstr.2019.100196
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items